Similar articles

• Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.

  Pinto NM, Soskolne EI, Pearlman MD, Faix RG. Pinto NM, et al. J Perinatol. 2003 Jun;23(4):265-71. doi: 10.1038/sj.jp.7210899. J Perinatol. 2003. PMID: 12774131
• Intrapartum antibiotic prophylaxis: making an evidence-based selection.

  Edwards RK, Duff P. Edwards RK, et al. Pediatrics. 2006 Jan;117(1):255-6; author reply 256-7. doi: 10.1542/peds.2005-2333. Pediatrics. 2006. PMID: 16396894 No abstract available.
• Control of perinatal group B streptococcal sepsis: efficacy of single injection of aqueous penicillin at birth.

  Steigman AJ, Bottone EJ, Hanna BA. Steigman AJ, et al. Mt Sinai J Med. 1978 Nov-Dec;45(6):685-93. Mt Sinai J Med. 1978. PMID: 368609 No abstract available.
• [Obstetrical management of Streptococcus agalactiae].

  Quentin R, Morange-Saussier V, Watt S. Quentin R, et al. J Gynecol Obstet Biol Reprod (Paris). 2002 Oct;31(6 Suppl):4S65-4S73. J Gynecol Obstet Biol Reprod (Paris). 2002. PMID: 12451360 Review. French.
• Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis.

  Schrag SJ, Stoll BJ. Schrag SJ, et al. Pediatr Infect Dis J. 2006 Oct;25(10):939-40. doi: 10.1097/01.inf.0000239267.42561.06. Pediatr Infect Dis J. 2006. PMID: 17006292 Review. No abstract available.